Curaleaf rebuts Aurora's claims, defending its $5B acquisition offer as fair and beneficial for shareholders.
Curaleaf Holdings has released a detailed fact sheet countering Aurora Cannabis's criticisms of its $5 billion acquisition proposal. Curaleaf argues its offer includes one of the highest premiums in Canadian M&A history and highlights Aurora's poor f...
